Research and development company Skinvisible, Inc. (OTCQB: SKVI) has set its sights on the burgeoning global markets for skincare, dermatology and over-the-counter products.
Marijuana Industry
Skinvisible, Inc. (SKVI) Targets Global Skincare Market Projected to Reach $135B by 2021
Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market projected to reach $135 billion by 2021.
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Driving Cannabis Costs Down While Meeting Patient Needs
Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, is creating a consistent, organically grown, pesticide-free standardized product that is keeping costs down and investors excited.
Grey Cloak Tech Inc. (GRCK) is “One to Watch”
Grey Cloak Tech Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, targets the rapidly growing cannabinoid (CBD) market through its wholly owned subsidiary Eqova Life Sciences.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Unlocks Ability to Produce 90+ Cannabinoids through Biosynthesis
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinformatics database assessment tool.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Presenting at Cannabis-Based Science & Medicine Conference
InMed Pharmaceuticals this morning said that it will be presenting twice at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference.
Marijuana Company of America (MCOA) Delivers with Unique Marketing, Distribution Platforms
Marijuana Company of America (OTC: MCOA) is a unique corporation with a strategic business structure that functions as an umbrella, bringing together a diverse portfolio of investments and joint ventures within the legal cannabis industry.
India Globalization Capital, Inc. (NYSE: IGC) Targets Multiple Health Concerns with Cannabis-based Therapies
The company’s most recent research and development focus continues to be on readying a line of cannabis-based products targeting Alzheimer’s disease.
Weed is the new craft beer, says former Budweiser exec: 'Ignore it at your peril' - From Financial Post
Chris Burggraeve is one of many entrepreneurs and investors increasingly flocking to the cannabis industry from the traditional business world
Economic Impact of Biosynthesis on the Cannabis Industry
InMed Pharmaceuticals has developed a proprietary process capable of extracting all 90+ cannabinoids in a laboratory setting.
Investors Could Reap Global Rewards of Research into Medical Cannabis Science
Cannabis companies have ramped up their efforts to make new scientific discoveries related to the plant’s medical uses.
Leaders in Medical Marijuana and the Global Alzheimer’s Markets
Investors interested in medicinal marijuana and/or Alzheimer’s treatments will find themselves looking at a global landscape of key players.
Innovation Drives Value for Leading Cannabis Biotechs
As an increasing volume of scientific research leans toward the efficacy of cannabis-based drugs, innovative biotech companies are advancing their R&D to develop therapeutic candidates that envelop the potential health benefits of the marijuana plant.
Rising Demand for Cannabis Oils Pushes Canada’s Producers into Overdrive
As one of Canada’s first licensed cannabis producers, ABcann is significantly ahead of the curve when it comes to production capacities.
Skinvisible, Inc. (SKVI) Subsidiary Inks License Agreement for US Distribution of Topical Cannabis Products
Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) announced on November 16 that it has formed a new subsidiary, Ovation Science Inc., and that Ovation has inked a definitive license agreement with Lighthouse Strategies, LLC.